Evidence map›Paper›PMID 30305476›Full record

ArticleJournal of clinical and experimental hematopathology : JCEH2018

Successful treatment of an elderly Langerhans cell sarcoma patient by EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) chemotherapy.

Toshihiro Matsukawa, Keito Suto, Hiroaki Miyoshi, Kazuo Oshimi, Koichi Ohshima, Takuto Miyagishima

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and experimental hematopathology : JCEH, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Toshihiro MatsukawaDepartment of Hematology, Kushiro Rosai Hospital, Kushiro, Japan.
Keito SutoDepartment of Hematology, Kushiro Rosai Hospital, Kushiro, Japan.
Hiroaki MiyoshiDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Kazuo OshimiDepartment of Hematology, Kushiro Rosai Hospital, Kushiro, Japan.
Koichi OhshimaDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Takuto MiyagishimaDepartment of Hematology, Kushiro Rosai Hospital, Kushiro, Japan.
Kushiro Rosai Hospital · JPKurume University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDoxorubicinEtoposideHumansLangerhans Cell SarcomaMalePrednisoneSkin NeoplasmsVincristineCyclophosphamideDoxorubicinEtoposidePrednisoneVincristineBRAF V600E mutationEPOCHLangerhans cell sarcomaMerkel cell polyoma virus

Identifiers

PMID30305476
PMCPMC6407472
OpenAlexW2897663338

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.